HomeSNPHY • OTCMKTS
add
Santen Pharmaceutical ADR Representing Ord Shs
Previous close
$10.74
Day range
$9.94 - $10.34
Year range
$8.95 - $13.00
Market cap
543.47B JPY
Avg Volume
19.67K
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 71.63B | -2.43% |
Operating expense | 29.41B | -7.03% |
Net income | 8.14B | -8.21% |
Net profit margin | 11.36 | -5.96% |
Earnings per share | — | — |
EBITDA | 15.05B | -12.75% |
Effective tax rate | 22.06% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 84.44B | 30.46% |
Total assets | 409.08B | -4.19% |
Total liabilities | 120.83B | 0.25% |
Total equity | 288.25B | — |
Shares outstanding | 349.15M | — |
Price to book | 0.01 | — |
Return on assets | 6.35% | — |
Return on capital | 9.02% | — |
Cash Flow
Net change in cash
| (JPY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 8.14B | -8.21% |
Cash from operations | 16.17B | -35.81% |
Cash from investing | -3.46B | -219.37% |
Cash from financing | -13.29B | -125.23% |
Net change in cash | -5.30B | -127.59% |
Free cash flow | 11.24B | -49.67% |
About
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
Founded
1890
Headquarters
Website
Employees
3,744
